Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 142441 - 142460 out of 485545 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Estonia | (L01EA06) asciminib | SCEMBLIX, õhukese polümeerikattega tablett, 20mg N60 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited |
Estonia | (L01EA06) asciminib | SCEMBLIX, õhukese polümeerikattega tablett, 40mg N60 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisEuropharmLimited |
Estonia | (L01EB04) osimertinib | TAGRISSO tablett 80mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
Estonia | (L01EC02) dabrafenib | TAFINLAR kapsel 75mg N120 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited |
Estonia | (L01ED02) ceritinib | ZYKADIA kapsel 150mg N150 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisEuropharmLimited |
Estonia | (L01ED03) alectinib | ALECENSA kõvakapsel 150mg N224 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RocheRegistrationGmbH |
Estonia | (L01ED04) brigatinib | ALUNBRIG tablett 180mg N28 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaAS |
Estonia | (L01ED04) brigatinib | ALUNBRIG tablett 30mg N28 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaAS |
Estonia | (L01ED04) brigatinib | ALUNBRIG tablett 90mg N28 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | TakedaPharmaA/S |
Estonia | (L01ED05) lorlatinib | LORVIQUA õhukese polümeerikattega tablett 100mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG |
Estonia | (L01ED05) lorlatinib | LORVIQUA õhukese polümeerikattega tablett 25mg N90 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | PfizerEuropeMAEEIG |
Estonia | (L01EE01) trametinib | MEKINIST tablett 0,5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited |
Estonia | (L01EE01) trametinib | MEKINIST tablett 2mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NovartisEuropharmLimited |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 100mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 125mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EF01) palbociclib | IBRANCE õhukese polümeerikattega tablett 75mg N21 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerEuropeMAEEIG |
Estonia | (L01EG02) everolimus (neoplastic diseases) | AFINITOR tablett 10mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited |
Estonia | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS NORAMEDA tablett 10mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | UABNorameda |
Estonia | (L01EG02) everolimus (neoplastic diseases) | AFINITOR tablett 5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited |
Estonia | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS NORAMEDA tablett 5mg N30 | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | UABNorameda |